In the News
ZERONA® in the June 2010 issue of Fitness Rx
ZERONA® in Woman’s World, April 19, 2010
ZERONA® in Muscle Development Magazine – May 2008
Harper's Bazaar
ZERONA® in Harper's Bazaar
Harper's Bazaar
New Year, New You
Marie Claire
No-Pain Thigh-Shrinking Laser ZERONA
Harper's Bazaar
Arms Are the New Face
Allure Magazine
Scalpel News - Lasered Thin
Harper's Bazaar
20 Beauty Buys & Ideas
The Aesthetic Guide
ZERONA Invents New Body Shaping Model
Star Magazine
You Can Have a Firmer Bod Too
Zerona®-Ultra
» Click here to see a schedule of FREE information seminar dates
BREAKING NEWS
FDA Grants Market Clearance for Erchonia's Zerona Laser
The Zerona is the first non-invasive aesthetic device to receive FDA market clearance in the U.S. for circumferential reduction of the waist, hips, and thighs.
» Click here for more info from Allure Magazine
» Click here for more info from MyZerona Website
Revolutionize your body with ZERONA®
Finally, a clinically proven alternative to losing fat and inches...ZERONA®, a non-invasive body slimming procedure, allows physicians to help patients enjoy better health and wellbeing. The safest and most researched low-level laser in the world, ZERONA® gives physicians the opportunity to deliver a proven way to help your patients painlessly reduce fat and inches.
The ZERONA® Technology
Designed to deliver results without the dangers associated with invasive body contouring surgery, ZERONA® painlessly reduces fat in the tissue under the skin. ZERONA® allows the body to safely eliminate fat while reducing inches from target areas, slimming, and reshaping body lines while tightening and toning loose skin.
A revolutionary method that delivers results while allowing patients to remain active during treatment, ZERONA® supports physicians in their quest to deliver optimum care and well being to their patients.
ZERONA® produces remarkable fat reduction results for patients. Clinically proven safe and effective through a double-blind, randomized, multi-site, and placebo-controlled study. During clincial trials the average patient lost a total of 3.64 inches from their waist, hips, and thighs.
In clinical use, because physicians are able to advise patients on a protocol to achieve better results that includes staying hydrated and moderate exercise, most ZERONA patients are experiencing losses greater than what was reported in the clinical trials. To learn more about patient satisfaction and what leading physicians have to say about ZERONA® and its treatment protocol
Only Two Weeks To Success with ZERONA®
ZERONA® does not require an extensive time commitment. Each treatment lasts only 40 minutes. A suggested treatment schedule is: Mon - Wed - Fri or Tues - Thurs - Sat visits, for a total of six treatments over two weeks. (For maximum results patients should not wait more than three days between treatments.)
From Theory to Therapy
ZERONA® utilizes the Erchonia® Laser Scanner, the safest and most researched low-level laser in the world. Initially designed and FDA approved for use during liposuction, the non-invasive Erchonia laser is applied to emulsify the adipose tissue and release excess fat into the interstitial space. From there, fat is passed through the body during its normal course of detoxification.
Whether performing traditional liposuction procedures or following the new ZERONA® protocol, physicians can be confident they are treating their patients with the safest and most researched low level laser in the world.
The ZERONA® procedure has been proven through a double-blind, randomized, multi-site and placebo-controlled clinical study in which patients, on average, lost 3.64 inches from their waist, hips, and thighs. These results were dramatic compared to the placebo group, which only lost an average of half an inch over the same time period.
This animation shows:
- Healthy adipose cells
- Fat droplets seeping from the cell membrane
- Collapse of adipose cell-emulsification
The remarkable images above demonstrate the low-level laser's ability to emulsify adipose tissue. The pictures highlight the safe collapse of the rigid adipose cell and the secretion of triglycerides and fatty acid from the cell.
How Triglycerides and Fatty Acids Escape with ZERONA®
These images show the formation of a transitory pore forming in the bi-lipid membrane of an adipose cell. This pore is the direct result of safe, low-level laser stimulation and the reason why the triglycerides and fatty acids are able to move into the interstitial space. The tiny pore causes no damage to the cell. It simply allows the fatty content to safely evacuate the cell.
The ZERONA® process is well supported by scientific research and analysis. The specification configurations for ZERONA® are:
- Configuration: 5-3b Line Generated Laser Diode Modules
- Wavelength: 635nm
- Modulation Constant Wave (CW)-1,000 Hz
- Programming: 4 Time Saving Preset Programs
- Display: 8" Full Color TFT Touch Panel Control Center
- Adjustments 44" Vertical Arm Height Adjustment
- Power Source 100-240VAC 50-60Hz
- Chassis: Powder Coated Metal Frame for Ease of Cleaning, 4 Anti-Static Casters (2 Locking)
- Housing: Thermoformed of Non-Allergen Material/Plastic
- Accessories 2-Keys, Laser Safety Glasses
Clinical Research Papers
Click on an image to view higher resolution version
Consultation Request Form
Step 1: to book your complimentary consultation, please fill out the form below.
Zerona® in the News
ABC Nightline
"Facelift for a Job Lift"
From face lifts to tummy tucks, extreme measures to improve a resume.
Watch Video >
ZERONA® Fat Reduction As Seen on The Doctors Show
See how ZERONA® helped this mom get her pre-baby body back and lose 5 inches.
Play Video >
